J P M O R G A N North America Equity Research 14 August 2026 U.S. SMid Biotech ACAD / CYTK / XENE / BHVN – Weekly Rx Trends Below, we highlight the latest trends in IQVIA U.S. prescription data for key commercial products in our coverage universe and relevant competitors. The data below for Nuplazid, Camzyos and select epilepsy drugs are updated through August 7, 2026. Tessa T Romero AC (1-212) 622-4484 tessa.t.romero@jpmchase.com | Company | Drug | Approved Indication | | --- | --- | --- | | ACAD | Nuplazi ...